Intellipharmaceutics International Inc. (IPCI)

[Tekterra]

You would think management have planed things out so that they don't need to dilute the stock and their own holdings again come year end. This makes logical sense and it was in line with what they said about looking at deals after Rexista filing.

If they don't think the 5 million in last round of fundraising was enough to get them to the point of inking a deal on Rexista and an up front payment they probably would have raised more funding in the last round.

I am interested to see if our predictions are correct. And, now it all makes more sense. If our predictions are correct, we should see a pretty good run by year end. The filing itself would probably draw some attention but probably won't be too much of a run up. I see it possibly go over 2 dollars and maybe reaching 3$.

But, signing a deal on Rexista and a big up front payment is likely going to send this beyond 3$ dollars. Approval early 2017 will keep getting higher. There would be opportunities to sell and get back in on the pull backs to accumulate shares.